V

Vaxart
D

VXRT

0.46340
USD
-0.00
(-0.56%)
مغلق
حجم التداول
2,795
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
105,758,516
أصول ذات صلة
BNTX
BNTX
-0.380
(-0.38%)
98.700 USD
I
INO
-0.06000
(-2.98%)
1.95500 USD
MRNA
MRNA
-0.820
(-3.03%)
26.280 USD
N
NVAX
-0.04000
(-0.55%)
7.25000 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
المزيد
الأخبار المقالات

العنوان: Vaxart

القطاع: Healthcare
الصناعة: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.